Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors
Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis with renal involvement requires treatment with potentially toxic drugs to reduce morbidity and mortality, and there is a major challenge to determine clinical and histological features predictive of renal prognosis. The aim of our study...
Saved in:
Published in | Nephrology, dialysis, transplantation Vol. 30; no. 7; pp. 1185 - 1192 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.07.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis with renal involvement requires treatment with potentially toxic drugs to reduce morbidity and mortality, and there is a major challenge to determine clinical and histological features predictive of renal prognosis. The aim of our study was to evaluate the use of the 2010 international histological classification for ANCA-associated glomerulonephritis (AAGN) as a predictor of renal outcome when used in conjunction with other prognostic factors.
One hundred and four patients with AAGN treated at our centre were included: 23 were classified as focal, 26 as crescentic, 48 as mixed and 7 as sclerotic. Renal outcomes were based on estimated glomerular filtration rate (eGFR) at 1 and 5 years, and on renal survival.
By univariate analysis, patients in the focal class had the best renal outcome, those in the sclerotic class the worst outcome, and those in the mixed and crescentic classes had intermediate renal survival. There was no significant difference in outcome between the mixed and crescentic classes. In multivariate models, histological class did not improve model fit or associate with renal outcome after adjusting for established prognostic factors. Lower percentage of normal glomeruli, greater degree of tubular atrophy (TA), MPO-ANCA positivity, increasing age and lower starting eGFR, all correlated with poorer renal outcomes.
We conclude that, in our cohort of patients, the international histological classification is predictive of renal outcome in AAGN, but did not appear to be additionally informative over other established prognostic factors in multivariate analysis. However, it may be of value to combine the current histological classification with other established parameters, such as TA and percentage normal glomeruli. |
---|---|
AbstractList | Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis with renal involvement requires treatment with potentially toxic drugs to reduce morbidity and mortality, and there is a major challenge to determine clinical and histological features predictive of renal prognosis. The aim of our study was to evaluate the use of the 2010 international histological classification for ANCA-associated glomerulonephritis (AAGN) as a predictor of renal outcome when used in conjunction with other prognostic factors.
One hundred and four patients with AAGN treated at our centre were included: 23 were classified as focal, 26 as crescentic, 48 as mixed and 7 as sclerotic. Renal outcomes were based on estimated glomerular filtration rate (eGFR) at 1 and 5 years, and on renal survival.
By univariate analysis, patients in the focal class had the best renal outcome, those in the sclerotic class the worst outcome, and those in the mixed and crescentic classes had intermediate renal survival. There was no significant difference in outcome between the mixed and crescentic classes. In multivariate models, histological class did not improve model fit or associate with renal outcome after adjusting for established prognostic factors. Lower percentage of normal glomeruli, greater degree of tubular atrophy (TA), MPO-ANCA positivity, increasing age and lower starting eGFR, all correlated with poorer renal outcomes.
We conclude that, in our cohort of patients, the international histological classification is predictive of renal outcome in AAGN, but did not appear to be additionally informative over other established prognostic factors in multivariate analysis. However, it may be of value to combine the current histological classification with other established parameters, such as TA and percentage normal glomeruli. Background Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis with renal involvement requires treatment with potentially toxic drugs to reduce morbidity and mortality, and there is a major challenge to determine clinical and histological features predictive of renal prognosis. The aim of our study was to evaluate the use of the 2010 international histological classification for ANCA-associated glomerulonephritis (AAGN) as a predictor of renal outcome when used in conjunction with other prognostic factors. Methods One hundred and four patients with AAGN treated at our centre were included: 23 were classified as focal, 26 as crescentic, 48 as mixed and 7 as sclerotic. Renal outcomes were based on estimated glomerular filtration rate (eGFR) at 1 and 5 years, and on renal survival. Results By univariate analysis, patients in the focal class had the best renal outcome, those in the sclerotic class the worst outcome, and those in the mixed and crescentic classes had intermediate renal survival. There was no significant difference in outcome between the mixed and crescentic classes. In multivariate models, histological class did not improve model fit or associate with renal outcome after adjusting for established prognostic factors. Lower percentage of normal glomeruli, greater degree of tubular atrophy (TA), MPO-ANCA positivity, increasing age and lower starting eGFR, all correlated with poorer renal outcomes. Conclusions We conclude that, in our cohort of patients, the international histological classification is predictive of renal outcome in AAGN, but did not appear to be additionally informative over other established prognostic factors in multivariate analysis. However, it may be of value to combine the current histological classification with other established parameters, such as TA and percentage normal glomeruli. |
Author | Tam, Frederick W K Cook, Terence Rodriquez-Cubillo, Beatriz Griffith, Megan Levy, Jeremy B Salama, Alan D Tarzi, Ruth M Caplin, Benjamin Tanna, Anisha Cairns, Tom D Guarino, Laura Pusey, Charles D |
Author_xml | – sequence: 1 givenname: Anisha surname: Tanna fullname: Tanna, Anisha organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 2 givenname: Laura surname: Guarino fullname: Guarino, Laura organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 3 givenname: Frederick W K surname: Tam fullname: Tam, Frederick W K organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 4 givenname: Beatriz surname: Rodriquez-Cubillo fullname: Rodriquez-Cubillo, Beatriz organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 5 givenname: Jeremy B surname: Levy fullname: Levy, Jeremy B organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 6 givenname: Tom D surname: Cairns fullname: Cairns, Tom D organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 7 givenname: Megan surname: Griffith fullname: Griffith, Megan organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 8 givenname: Ruth M surname: Tarzi fullname: Tarzi, Ruth M organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 9 givenname: Benjamin surname: Caplin fullname: Caplin, Benjamin organization: UCL Centre for Nephrology, Royal Free Hospital, London, UK – sequence: 10 givenname: Alan D surname: Salama fullname: Salama, Alan D organization: UCL Centre for Nephrology, Royal Free Hospital, London, UK – sequence: 11 givenname: Terence surname: Cook fullname: Cook, Terence organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK – sequence: 12 givenname: Charles D surname: Pusey fullname: Pusey, Charles D email: c.pusey@imperial.ac.uk organization: Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK c.pusey@imperial.ac.uk |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25016608$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kd1q3DAQhUVISTZpb_oARZel4GYs2Wu7dyX0DxZ601ybWf14VWSNK8mFfaq8YpTdtBdCGs05nwadG3YZKBjG3tbwsYZB3gWd7ya7CtldsE3dbKESsm8v2aY06wpaGK7ZTUq_AWAQXXfFrkUL9XYL_YY97ihMVTZx5rRmRbPhZDmG7Kpg1hxpOTjP1THT4jHNp86e9LHClEg5zEbzyRdbXH2ZajlEl136xM1f9CtmR-GZlw-Gu1BeCacr9PzgUiZPk1OlUAWdnC3nkwGD5lQskS-RpkApO8UtqkwxvWavLPpk3rzst-zh65df99-r3c9vP-4_7yrVCJGrwVrVd9BrJQdr9rptaigfgc0eoOmGtu6EtW0vWoXYSGuNhkFJKRVa1AK38pa9P3PLCH9Wk_I4u6SM9xgMrWksAFEWtLJIP5ylKlJK0dhxiW7GeBxrGJ8DGktA4zmgIn73wl33s9H_pf8SkU_dm5XC |
CitedBy_id | crossref_primary_10_1016_j_nefroe_2018_02_003 crossref_primary_10_3390_ijms21197319 crossref_primary_10_1093_ckj_sfaa073 crossref_primary_10_1093_rheumatology_keae336 crossref_primary_10_1007_s40620_021_01208_6 crossref_primary_10_1080_0886022X_2022_2114368 crossref_primary_10_1007_s40620_023_01855_x crossref_primary_10_1093_ndt_gfae018 crossref_primary_10_1016_j_berh_2018_08_011 crossref_primary_10_1016_j_ekir_2023_05_029 crossref_primary_10_1038_s41598_021_92629_7 crossref_primary_10_2215_CJN_04800516 crossref_primary_10_1016_j_ekir_2019_02_005 crossref_primary_10_2215_CJN_06200616 crossref_primary_10_3899_jrheum_170006 crossref_primary_10_1155_2018_3251517 crossref_primary_10_1186_s12882_019_1487_7 crossref_primary_10_3389_fimmu_2021_631055 crossref_primary_10_1371_journal_pone_0236051 crossref_primary_10_1007_s00393_017_0394_1 crossref_primary_10_1136_bmjopen_2016_015668 crossref_primary_10_1159_000480443 crossref_primary_10_1128_mbio_00541_24 crossref_primary_10_3390_ijms241914436 crossref_primary_10_5527_wjn_v7_i3_71 crossref_primary_10_3899_jrheum_220818 crossref_primary_10_1007_s00467_019_04228_4 crossref_primary_10_23876_j_krcp_20_184 crossref_primary_10_1007_s10157_018_1656_1 crossref_primary_10_1007_s11926_021_01002_0 crossref_primary_10_1007_s10157_020_01925_5 crossref_primary_10_3389_fmed_2021_783757 crossref_primary_10_1155_2018_7581567 crossref_primary_10_1007_s00296_021_05011_1 crossref_primary_10_1016_j_autrev_2022_103139 crossref_primary_10_1016_j_humpath_2016_05_015 crossref_primary_10_1272_jnms_JNMS_2018_85_41 crossref_primary_10_4103_ijn_IJN_108_20 crossref_primary_10_1111_cei_13530 crossref_primary_10_2215_CJN_09600620 crossref_primary_10_1038_s41584_022_00819_y crossref_primary_10_4103_1319_2442_279939 crossref_primary_10_1038_s41598_023_41811_0 crossref_primary_10_1093_ndt_gfw336 crossref_primary_10_1007_s10067_020_04936_5 crossref_primary_10_1007_s11255_018_1941_7 crossref_primary_10_3390_jcm10122682 crossref_primary_10_2215_CJN_14561119 crossref_primary_10_1007_s11255_022_03371_6 crossref_primary_10_3899_jrheum_160866 crossref_primary_10_1007_s10157_017_1498_2 crossref_primary_10_1016_j_nefro_2017_08_001 crossref_primary_10_1007_s10067_021_05862_w crossref_primary_10_1681_ASN_0000000000000274 crossref_primary_10_1007_s40620_017_0412_z crossref_primary_10_1186_s12916_023_02755_4 crossref_primary_10_1002_art_40471 crossref_primary_10_1007_s11926_016_0619_3 crossref_primary_10_1186_s13075_015_0654_x crossref_primary_10_1007_s10067_017_3721_7 crossref_primary_10_1093_ckj_sfae125 crossref_primary_10_46497_ArchRheumatol_2021_8687 crossref_primary_10_3389_fped_2021_656307 crossref_primary_10_1016_j_xkme_2021_04_005 crossref_primary_10_1080_07853890_2023_2289614 crossref_primary_10_1186_s12882_015_0082_9 crossref_primary_10_1155_2018_6369814 crossref_primary_10_3390_jcm10071538 crossref_primary_10_15591_mtp_2014_036 crossref_primary_10_1093_ndt_gfw046 crossref_primary_10_1371_journal_pone_0213215 crossref_primary_10_1155_2018_5653612 crossref_primary_10_3389_fimmu_2020_607261 crossref_primary_10_1016_j_kint_2018_07_020 crossref_primary_10_1177_10815589231186534 crossref_primary_10_1016_j_kint_2017_03_014 crossref_primary_10_1177_1759720X221125979 crossref_primary_10_1007_s11255_018_1888_8 crossref_primary_10_1016_j_humpath_2016_01_015 crossref_primary_10_1038_nrrheum_2016_123 crossref_primary_10_3390_medicina54020017 crossref_primary_10_1186_s40001_023_01113_7 |
Cites_doi | 10.1111/j.1440-1797.2011.01525.x 10.1046/j.1523-1755.2000.00080.x 10.1136/ard.2009.109389 10.1053/ajkd.2002.32799 10.2215/CJN.13071211 10.1186/1471-2369-14-210 10.1038/ki.2009.168 10.1056/NEJMoa1108735 10.1002/art.37715 10.1136/ard.2010.137778 10.1046/j.1523-1755.2002.00089.x 10.1681/ASN.2011040330 10.1681/ASN.2012090912 10.1111/j.1365-2249.2011.04359.x 10.1681/ASN.2010050477 10.1097/00002281-200301000-00003 10.1093/ndt/gfr643 10.2147/TCRM.S6112 10.1681/ASN.2005080870 10.1093/ndt/gfr127 10.1111/j.1523-1755.2004.00443.x 10.1146/annurev-pathol-011811-132453 10.1002/art.34562 10.1053/ajkd.2003.50115 10.1093/ndt/gfs428 10.1016/S0272-6386(03)00025-8 10.1046/j.1523-1755.1999.00758.x |
ContentType | Journal Article |
Copyright | The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. |
Copyright_xml | – notice: The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 |
DOI | 10.1093/ndt/gfu237 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2385 |
EndPage | 1192 |
ExternalDocumentID | 10_1093_ndt_gfu237 25016608 |
Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Arthritis Research UK grantid: 18235 – fundername: Versus Arthritis grantid: 18235 |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .XZ .ZR 0R~ 123 18M 1TH 29M 2WC 4.4 482 48X 53G 5RE 5VS 5WA 5WD 6.Y 70D AABZA AACZT AAHTB AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWDT ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABOCM ABPEJ ABPTD ABQLI ABQNK ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACYHN ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFSHK AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C45 CAG CDBKE CGR COF CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EIHJH EJD ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MHKGH ML0 N9A NGC NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SDH TCURE TEORI TJX TMA TR2 W8F WH7 WOQ X7H X7M YAYTL YKOAZ YXANX ZGI ZKX ZXP ~91 AAYXX ABEJV AHMMS CITATION 7T5 H94 |
ID | FETCH-LOGICAL-c422t-9ffc8708dc39febd5410050a4b004795172ff5825caa43ffed09c333cafad2a63 |
ISSN | 0931-0509 |
IngestDate | Wed Dec 04 10:49:34 EST 2024 Fri Dec 06 05:48:52 EST 2024 Wed Oct 16 00:44:25 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | glomerulonephritis ANCA clinical outcome vasculitis renal pathology |
Language | English |
License | The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c422t-9ffc8708dc39febd5410050a4b004795172ff5825caa43ffed09c333cafad2a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/ndt/article-pdf/30/7/1185/17171707/gfu237.pdf |
PMID | 25016608 |
PQID | 1722172053 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1722172053 crossref_primary_10_1093_ndt_gfu237 pubmed_primary_25016608 |
PublicationCentury | 2000 |
PublicationDate | 2015-07-01 |
PublicationDateYYYYMMDD | 2015-07-01 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Nephrology, dialysis, transplantation |
PublicationTitleAlternate | Nephrol Dial Transplant |
PublicationYear | 2015 |
References | 2015102300423609000_30.7.1185.26 2015102300423609000_30.7.1185.27 2015102300423609000_30.7.1185.24 2015102300423609000_30.7.1185.25 2015102300423609000_30.7.1185.22 2015102300423609000_30.7.1185.23 2015102300423609000_30.7.1185.20 2015102300423609000_30.7.1185.21 2015102300423609000_30.7.1185.1 2015102300423609000_30.7.1185.3 2015102300423609000_30.7.1185.2 2015102300423609000_30.7.1185.9 2015102300423609000_30.7.1185.8 2015102300423609000_30.7.1185.19 2015102300423609000_30.7.1185.5 2015102300423609000_30.7.1185.17 2015102300423609000_30.7.1185.4 2015102300423609000_30.7.1185.18 2015102300423609000_30.7.1185.7 2015102300423609000_30.7.1185.15 2015102300423609000_30.7.1185.6 2015102300423609000_30.7.1185.16 2015102300423609000_30.7.1185.13 2015102300423609000_30.7.1185.14 2015102300423609000_30.7.1185.11 2015102300423609000_30.7.1185.12 2015102300423609000_30.7.1185.10 |
References_xml | – ident: 2015102300423609000_30.7.1185.14 doi: 10.1111/j.1440-1797.2011.01525.x – ident: 2015102300423609000_30.7.1185.26 doi: 10.1046/j.1523-1755.2000.00080.x – ident: 2015102300423609000_30.7.1185.11 doi: 10.1136/ard.2009.109389 – ident: 2015102300423609000_30.7.1185.19 doi: 10.1053/ajkd.2002.32799 – ident: 2015102300423609000_30.7.1185.24 doi: 10.2215/CJN.13071211 – ident: 2015102300423609000_30.7.1185.18 doi: 10.1186/1471-2369-14-210 – ident: 2015102300423609000_30.7.1185.13 doi: 10.1038/ki.2009.168 – ident: 2015102300423609000_30.7.1185.27 doi: 10.1056/NEJMoa1108735 – ident: 2015102300423609000_30.7.1185.2 doi: 10.1002/art.37715 – ident: 2015102300423609000_30.7.1185.25 doi: 10.1136/ard.2010.137778 – ident: 2015102300423609000_30.7.1185.8 doi: 10.1046/j.1523-1755.2002.00089.x – ident: 2015102300423609000_30.7.1185.10 doi: 10.1681/ASN.2011040330 – ident: 2015102300423609000_30.7.1185.17 doi: 10.1681/ASN.2012090912 – ident: 2015102300423609000_30.7.1185.9 doi: 10.1111/j.1365-2249.2011.04359.x – ident: 2015102300423609000_30.7.1185.15 doi: 10.1681/ASN.2010050477 – ident: 2015102300423609000_30.7.1185.3 doi: 10.1097/00002281-200301000-00003 – ident: 2015102300423609000_30.7.1185.16 doi: 10.1093/ndt/gfr643 – ident: 2015102300423609000_30.7.1185.20 doi: 10.2147/TCRM.S6112 – ident: 2015102300423609000_30.7.1185.7 doi: 10.1681/ASN.2005080870 – ident: 2015102300423609000_30.7.1185.21 doi: 10.1093/ndt/gfr127 – ident: 2015102300423609000_30.7.1185.12 doi: 10.1111/j.1523-1755.2004.00443.x – ident: 2015102300423609000_30.7.1185.1 doi: 10.1146/annurev-pathol-011811-132453 – ident: 2015102300423609000_30.7.1185.22 doi: 10.1002/art.34562 – ident: 2015102300423609000_30.7.1185.6 doi: 10.1053/ajkd.2003.50115 – ident: 2015102300423609000_30.7.1185.23 doi: 10.1093/ndt/gfs428 – ident: 2015102300423609000_30.7.1185.4 doi: 10.1016/S0272-6386(03)00025-8 – ident: 2015102300423609000_30.7.1185.5 doi: 10.1046/j.1523-1755.1999.00758.x |
SSID | ssj0009277 |
Score | 2.5115225 |
Snippet | Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis with renal involvement requires treatment with potentially toxic drugs to reduce morbidity and... Background Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis with renal involvement requires treatment with potentially toxic drugs to reduce... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1185 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Antibodies, Antineutrophil Cytoplasmic - blood Antibodies, Antineutrophil Cytoplasmic - classification Female Follow-Up Studies Glomerular Filtration Rate Glomerulonephritis - blood Glomerulonephritis - classification Glomerulonephritis - diagnosis Glomerulonephritis - mortality Humans International Agencies Kidney - pathology Male Middle Aged Multivariate Analysis Prognosis Survival Rate Young Adult |
Title | Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25016608 https://search.proquest.com/docview/1722172053 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuiHfDS4vgFpnGr7XNrRSq8mgPKBW9Wet9BIvEjoJ9aP4Uv4b_w8yuX4FUAi6WZcdeK9-nmdndmW8Iecni2GU8Ug64EuYEUew7PIGDQvXuDIyy1LjecXrGTs6DDxfhxWj0c5C1VFfZK7HZWVfyP6jCNcAVq2T_AdnupXABzgFfOALCcPwrjD-VxdxB2zop6woGMPN_-Ktyp1B1tS5XX_PFRFxW5Qpi5KW5k5Xy0uENJhBszhfw2LpelIUCWFHgyPTq6TTA2xyCfGvl0KgUt1ZTYACOGUf2AVyJN2VdJverKFEIum3rMwyFz3DArlYG61dQHAXPKyO4vuDFdprAjBe2gO2wwJbRXeYQkDw3DcRNkTfvf760kTnKZeTi2-RLv6T7uZRrFK7dOEd1ljfbT28UtivYDNdB3LDLmQU3Zm13wKYORCDh0Lg3mz6WxNHAUsPEKtzpQqy8ViHBBx7Pde1ZTZoBm1ZLQyeIHV3GpnHvSLv0xvbWNXId9RmxpcPb9x97LWgvilql3MQ_gKEO7ECoTN08uh0mXTH3MTHQ7Da51Uxe6KFl4h0yUsVdcuO0Sc-4R350hKQNIWmp6W-EpB0h6Q5C0j8J-Zr2dMT3AbfoFh3pkI50m44whqSGjrSnI23oeJ-cH7-bHZ04TUcQRwSeVzmJ1gIcTCyFn2iVyTBwUcCIB5lplRBCNK51GHuh4DzwtVZymgjf9wXXXHqc-Q_IXgHfv08oE5H0mYpcjR13MpbEMpMJDyC8dkPOszF50QKQrqzwS2oTNvwUEEstYmPyvMUmBbuMm228UGX9PYVPwd5v4OPG5KEFrXtPC_KjK-88Jjd7jj8he9W6Vk8h-q2yZ4ZLvwDDIsGU |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+outcome+of+anti-neutrophil+cytoplasm+antibody-associated+glomerulonephritis%3A+evaluation+of+the+international+histological+classification+and+other+prognostic+factors&rft.jtitle=Nephrology%2C+dialysis%2C+transplantation&rft.au=Tanna%2C+Anisha&rft.au=Guarino%2C+Laura&rft.au=Tam%2C+Frederick+W+K&rft.au=Rodriquez-Cubillo%2C+Beatriz&rft.date=2015-07-01&rft.eissn=1460-2385&rft.volume=30&rft.issue=7&rft.spage=1185&rft_id=info:doi/10.1093%2Fndt%2Fgfu237&rft_id=info%3Apmid%2F25016608&rft.externalDocID=25016608 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0931-0509&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0931-0509&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0931-0509&client=summon |